Stock CALT CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Calliditas Therapeutics AB Nasdaq

Equities

CALT

US13124Q1067

Real-time Estimate Cboe BZX
Other stock markets
 03:27:38 2024-05-21 pm EDT 		5-day change 1st Jan Change
21.66 USD -1.52% Intraday chart for Calliditas Therapeutics AB -4.82% -16.48%
05:12pm European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
May. 20 European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guggenheim Adjusts Calliditas Therapeutics' Price Target to $18 From $21, Keeps Neutral Rating
MT
HC Wainwright Initiates Coverage on Calliditas Therapeutics With Buy Rating, $60 Price Target
MT
Guggenheim Initiates Calliditas Therapeutics at Neutral With $18 Price Target
MT
HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates Buy Rating
MT
Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy Rating
MT
ANALYST RECOMMENDATIONS : Alibaba, Goldman Sachs, Monday.com, Shaftesbury, 3M Company...
Our Logo
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. CALT Stock
  5. News Calliditas Therapeutics AB
  6. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW